help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by AVILA, P. C.
Right arrow Articles by FAHY, J. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by AVILA, P. C.
Right arrow Articles by FAHY, J. V.

Am. J. Respir. Crit. Care Med., Volume 161, Number 6, June 2000, 2092-2095

Predictors of Late Asthmatic Response
Logistic Regression and Classification Tree Analyses

PEDRO C. AVILA, MARK R. SEGAL, HOFER H. WONG, HOMER A. BOUSHEY, and JOHN V. FAHY

Cardiovascular Research Institute, Department of Medicine, and the Department of Epidemiology and Biostatistics, University of California at San Francisco, San Francisco, California

To identify predictors of the late asthmatic response (LAR), we reviewed data from 60 asthmatic subjects who had undergone allergen challenge over the past 5 yr (33 females, age 31.4 ± 6.7 yr [mean ± SD], FEV1 90% ± 14% predicted). Variables considered likely predictors of LAR included baseline FEV1, PC20 methacholine (PC20), sputum eosinophil percent, and the decrease in FEV1 within 20 min of allergen challenge. A LAR (FEV1 >=  15% fall between 3 and 7 h after challenge) was documented in 57% of subjects. A variety of logistic regression methods revealed a significant inverse association between LAR and PC20 (odds ratio [OR] = 0.14 [95% CI = 0.03-0.66]) and a positive association between LAR and the decrease in FEV1 at 20 min (OR = 1.18 [1.04 -1.33]). Classification tree analysis revealed that a threshold of 0.25 mg/ml for PC20 was most predictive of LAR; LAR developed in 87% of those with PC20 =< 0.25 mg/ml (n = 23) and in 38% of those with PC20 > 0.25 mg/ml (n = 37). Notably, in subjects with PC20 > 0.25 mg/ml, the incidence of LAR increased from 38% to 57% if the allergen-induced decline in FEV1 at 20 min was >=  27%. Surprisingly, baseline FEV1 and percent eosinophils in induced sputum were not significantly associated with LAR. We conclude that a threshold value of 0.25 mg/ml for PC20 methacholine is a good predictor of LAR. Measuring the PC20 methacholine may be useful as a screening method to improve the efficiency of identifying asthmatic subjects with a LAR.




This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
M. J. TOBIN
Asthma, Airway Biology, and Allergic Rhinitis in AJRCCM 2000
Am. J. Respir. Crit. Care Med., November 1, 2001; 164(9): 1559 - 1580.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2000 American Thoracic Society